We’re enabling the development of genomic-based diagnostic tools to manage diseases that make up 80% of healthcare costs, such as dementia, diabetes, cardiovascular, and respiratory disease.
By diagnosing diseases early, we improve quality of life and health outcomes - reducing treatment costs and avoiding complications.
Accurately diagnose patients and categorize into subgroups with specific biological mechanisms
Gain deep insights to select the best treatments and care pathways for identified diseases
Benefit from more accurate and personalized risk scores to predict an individual’s personal risks
The use of genomic data to characterize and diagnose disease at the point of care is becoming commonplace in cancer and rare diseases but has yet to expand into more complex chronic diseases.
Our precision diagnostics solutions enable a personalized approach to treatment based on specific disease subgroups and underlying mechanisms.
We help focus healthcare resources on the individuals most at risk and most likely to benefit from specific interventions.
Our insights identify the factors that change the trajectory of more serious disease complications, which improve patient outcomes and reduce costs.
We identified clear differences in the genetic makeup and disease-associated metabolic pathways between T2 allergic and non-T2 asthma patients.
Our findings clearly demonstrate the differing biological drivers of T2 and non-T2 asthma, opening new options for better diagnostics and therapy selection, and novel drug targets and therapies that address the unmet medical need of non-T2 patients.
